Giuseppe Querques, MD, PhD, discusses the phenotypes of intermediate AMD and how they can help predict geographic atrophy (GA) development and progression. With new treatments available, identifying biomarkers of GA progression is important for ophthalmologists, and Querques suggests that in the future, treatments could be targeted based on these different phenotypes. The discussion took place at the FLORetina-ICOOR meeting in Rome. Querques reports consulting for several companies in the industry.
Source link
Identifying biomarkers of GA progression essential for retina experts
